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Abstract
Herein we present a clinical case of the Caroli syndrome caused by the compound heterozygous mutation in the PKHD1 gene. 
Histopathological assessment of liver detected biliary cirrhosis, numerous dilated bile ducts of various sizes, hyperplastic 
cholangiocytes containing a large amount of acid mucopolysaccharides, decreased ß-tubulin expression and increased prolif-
eration of cholangiocytes. A significant proportion of hepatic tissue was composed of giant cysts lined with a single layer of 
cholangiocytes, containing pus and bile in its lumen and surrounded by granulation tissue. An accumulation of neutrophils 
in the lumen of the bile ducts was observed, as well as an infiltration of the ducts and cysts surrounding connective tissue 
by  CD4+ and to a lesser extent  CD8+ lymphocytes. This may be caused by the expression of HLA-DR by cholangiocytes. 
Atrophy and desquamation of the epithelium of collecting tubules with the formation of microcysts were detected in the 
kidneys without a clinically significant loss of renal function. Morphopathogenetic mechanisms of the Caroli syndrome can 
be targets for a potential pathogenetic therapy and prevention of its manifestations and complications.
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Introduction
The Caroli syndrome (CS) is a rare (prevalence 1:1,000,000) 
autosomal recessive hereditary disease characterized by a 
cystic dilatation of the intrahepatic biliary ducts (IHBD) in 
combination with congenital portal fibrosis. The disease is 
caused by mutations in the PKHD1 gene, which contains 67 
exons and is localized in chromosome 6p21.1-p12. These 
mutations lead to a defect in the fibrocystin protein—a 
structural component of the primary cilia of the cholangio-
cytes—and cystogenesis [1].
There is a distinction between the CS and Caroli disease, 
which is characterized by isolated dilatation of large IHBD, 
the absence of congenital liver fibrosis, in which only one 
portion of the liver may be affected [2]. The syndrome and 
the disease were named after the French physician J.Caroli, 
who was the first to describe the manifestations of this con-
dition without concomitant congenital fibrosis in detail 
(1958) [3].
Case report
A male patient at the age of 37 was hospitalized with com-
plaints of severe epigastric pain, nausea and vomiting. The 
patient suffered cirrhosis of the liver of unclear etiology 
since childhood (upon admission: Child–Pugh class B, 
Model for End-Stage Liver Disease (MELD) Score 43), and 
had manifestations of portal hypertension. The patient was 
infected by the human immunodeficiency virus (HIV), and 
his Hepatitis B, C was negative, while drug and alcohol use 
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